Arcutis Biotherapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $129,861 | $105,398 | $129,503 | $99,219 |
Gross Profit | 118,922 | 95,614 | 117,815 | 90,534 |
EBITDA | 17,149 | -6,272 | 22,129 | 11,123 |
EBIT | 16,586 | -6,834 | 20,866 | 10,561 |
Net Income | 15,009 | -11,295 | 17,395 | 7,410 |
Net Change In Cash | 129,861 | 105,398 | 129,503 | 99,219 |
Free Cash Flow | 12,481 | 2,239 | 26,185 | -1,754 |
Cash | 34,121 | 34,762 | 42,907 | 47,120 |
Basic Shares | 135,898 | 129,365 | 135,635 | 132,885 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $376,072 | $196,542 | $59,606 | $3,686 |
Gross Profit | 339,377 | 177,414 | 54,619 | 2,932 |
EBITDA | 2,480 | -109,625 | -227,434 | -294,553 |
EBIT | -2,887 | -112,224 | -229,315 | -295,806 |
Net Income | -16,140 | -140,039 | -262,140 | -311,458 |
Net Change In Cash | 376,072 | 196,542 | 59,606 | 3,686 |
Free Cash Flow | -6,311 | -112,301 | -247,485 | -280,998 |
Cash | 42,907 | 71,335 | 88,398 | 53,641 |
Basic Shares | 127,234 | 120,958 | 69,305 | 55,032 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.11 |
2026-03-31 | -$0.09 |
2025-12-31 | $0.13 |
2025-09-30 | $0.06 |